In South Africa, Thembi Dlamini, 29, is screened at a clinical research site to participate in the trial. this would be a tectonic, historic event for HIV,” said Nelson L. Michael, director of the U.S. Military HIV Research Program, which led the Thailand study. Aruna Bhoola, a pharmacist at the Medical Research Council in Verulam, South Africa, checks samples of the HIV vaccine. That’s why we can’t cure it.”In 2007, South Africa was one site of a second phase of testing for an HIV vaccine developed by pharmaceutical giant Merck. “I want to be one of the ones who helped prevent this thing for the future.”Brown reported from South Africa, and Bernstein reported from Washington.

Source: Washington Post November 26, 2016 00:18 UTC